Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1651
This examiner grants 39% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 16614133 | BIOFERTILIZER AND METHODS OF MAKING AND USING SAME | Non-Final OA | President and Fellows of Harvard College |
| 17080505 | Methods for purification of polypeptides using polysorbates | Final Rejection | Hoffmann-La Roche Inc. |
| 17765960 | PURIFICATION OF PROTEINS AND VIRAL INACTIVATION | Non-Final OA | MERCK PATENT GMBH |
| 18073511 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING VAGUS NERVE ASSOCIATED DISEASES, DISORDERS, AND CONDITIONS | Non-Final OA | MarvelBiome, Inc. |
| 17621497 | RATIOMETRIC DETECTION OF LUCIFERASE ASSAYS USING A CALIBRATOR LUCIFERASE | Non-Final OA | TECHNISCHE UNIVERSITEIT EINDHOVEN |
| 18547468 | METHODS FOR LIGATION OF (POLY)PEPTIDES AND OLIGONUCLEOTIDES | Non-Final OA | Nanyang Technological University |
| 18117163 | Improved Cellulose to Cellobiose Conversion Process | Non-Final OA | SixRing Inc. |
| 18231204 | SPRAY DRIED EXTRACT | Non-Final OA | Sutro Biopharma, Inc. |
| 17256813 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Non-Final OA | Givaudan SA |
| 18262523 | DETECTING BETA-LACTAMASE ENZYME ACTIVITY | Non-Final OA | UNIVERSITE PARIS-SACLAY |
| 18391729 | A PROBIOTIC COMPOSITION FOR IMPROVING WHEY PROTEIN PROTEOLYSIS, AUGMENTING AMINO ACID PRODUCTION, AND IMPROVING LACTOSE DEGRADATION ABILITY | Non-Final OA | LACTOMASON CO., LTD. |
| 17080078 | ADENO-ASSOCIATED VIRUS VECTOR MEDIATED GENE THERAPY FOR OPHTHALMIC DISEASES | Non-Final OA | Ocugen, Inc. |
| 18348128 | MAD NUCLEASES | Non-Final OA | Inscripta, Inc. |
| 17767143 | COAGULATION ASSAY APPARATUS AND METHODS THEREOF | Final Rejection | Nova Biomedical Corporation |
| 18453221 | METHOD FOR EXPRESSING AND PURIFYING PROTEIN BY USING CSQ-TAG | Non-Final OA | ToolBio. Co |
| 18270856 | IMMUNOGENIC FUSION PROTEINS AGAINST INFECTIOUS ANIMAL DISEASES | Non-Final OA | NAVICURE BIOPHARMACEUTICALS LIMITED |
| 17290806 | SYSTEM AND METHOD FOR GENOME EDITING BASED ON C2C1 NUCLEASES | Non-Final OA | Institute of Zoology, Chinese Academy of Sciences |
| 18056629 | ENGINEERED AND CHIMERIC NUCLEASES | Final Rejection | Metagenomi Therapeutics, Inc. |
| 18069452 | PERSIMMON DIETARY FIBER FOR ITS USE WITH OTHER BENEFICIAL MICROORGANISMS | Final Rejection | UNIVERSIDAD MIGUEL HERNANDEZ DE ELCHE |
| 17602642 | PROCESSING ORGANIC WASTE USING A HIGHLY SPECIFIC D-LACTATE OXIDASE | Non-Final OA | TRIPLE W LTD. |
| 16981618 | B CELLS GENETICALLY ENGINEERED TO SECRETE FOLLISTATIN AND METHODS OF USING THE SAME TO TREAT FOLLISTATIN-RELATED DISEASES, CONDITIONS, DISORDERS AND TO ENHANCE MUSCLE GROWTH AND STRENGTH | Final Rejection | Immusoft Corporation |
| 17739660 | Compositions and Methods for Treating Elevated Secretory Activity | Final Rejection | BIOMADISON, INC. |
| 17424174 | A process for the bioproduction of glycolate | Final Rejection | Photanol B.V. |
| 17293464 | COMPOSITIONS FOR TREATING OXIDATIVE STRESS-ASSOCIATED SKIN DISEASES AND SKIN AGEING AND DIAGNOSIS OF OXIDATIVE STRESS-ASSOCIATED SKIN DISEASES | Final Rejection | S-Biomedic N.V. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy